Remed Co.,Ltd. (KOSDAQ:302550)
2,795.00
+20.00 (0.72%)
At close: Jan 23, 2026
Remed Revenue
Remed had revenue of 5.81B KRW in the quarter ending September 30, 2025, a decrease of -3.69%. This brings the company's revenue in the last twelve months to 24.26B, up 3.56% year-over-year. In the year 2024, Remed had annual revenue of 25.55B with 37.86% growth.
Revenue (ttm)
24.26B
Revenue Growth
+3.56%
P/S Ratio
3.56
Revenue / Employee
263.65M
Employees
92
Market Cap
86.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.55B | 7.02B | 37.86% |
| Dec 31, 2023 | 18.54B | -2.83B | -13.23% |
| Dec 31, 2022 | 21.36B | 1.17B | 5.79% |
| Dec 31, 2021 | 20.20B | 3.56B | 21.42% |
| Dec 31, 2020 | 16.63B | -1.92B | -10.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 120.30B |
| Genoray | 102.75B |
| DRGEM | 98.34B |
| JPI Healthcare | 52.79B |
| CU Medical Systems | 44.79B |
| Hironic | 33.18B |
| SELVAS Healthcare | 29.79B |
| Neofect | 20.50B |